SCHEMBL144007

SCHEMBL144007

[C]#CCCC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL231424 0.90
SCHEMBL8208077 0.87
SCHEMBL2449857 0.87
SCHEMBL3628409 0.87
SCHEMBL3626508 0.87
SCHEMBL3626234 0.87
SCHEMBL8212987 0.87
SCHEMBL3628842 0.87
SCHEMBL979431 0.87
SCHEMBL1278716 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2642 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321573-B Substituted pyrimidine compound as phosphatidylinositol 3-kinase delta inhibitor and application thereof 南京圣和药业股份有限公司 2022-05-27 CN claimed
CN-112321573-A Substituted pyrimidine compound as phosphatidylinositol 3-kinase delta inhibitor and application thereof 南京圣和药业股份有限公司 2021-02-05 CN claimed
EP-3266774-B1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF NANJING SANHOME PHARMACEUTICAL CO LTD (CN) 2019-09-04 EP claimed
US-10077258-B2 Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2018-09-18 US claimed
US-20180037576-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2018-02-08 US claimed
EP-3266774-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) 2018-01-10 EP claimed
US-8461072-B2 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-06-11 US claimed
US-7994086-B2 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-08-09 US claimed
US-20110092658-A1 Late Transition Metal Catalysts for Olefin Oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-21 US claimed
WO-2009005839-A2 COMPOUNDS AND METHODS OF USE THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICE (US) 2009-01-08 WO claimed
US-20050003955-A1 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2005-01-06 US claimed
US-20040138056-A1 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2004-07-15 US claimed
WO-2004037869-A2 LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-05-06 WO claimed
WO-2004037837-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-05-06 WO claimed
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders INMED PHARMACEUTICALS INC. 2024-07-23 US disclosed
US-20240240048-A1 POLYROTAXANE HAVING AMINO GROUP DENKA COMPANY LIMITED (JP) 2024-07-18 US disclosed
US-20240238427-A1 METHODS OF TREATING AN EYE DISORDER KODIAK SCIENCES INC. 2024-07-18 US disclosed
US-4345071-A AZIDOALKYL-HETEROCYCLIC AMIDINE INTERMEDIATES LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) 1982-08-17 US disclosed
US-4259333-A ANTIBIOTICS, BACTERICIDES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 1981-03-31 US disclosed
US-4229443-A Derivatives of penicillanic acid LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) 1980-10-21 US disclosed